In this 3-minute video, Dr Ilan Melnick discusses the practicalities of prescribing Abilify Asimtufii: When can you transition patients, what are the barriers and how can you help make gluteal injections more tolerable.
Abilify Asimtufii PBS Information: Authority required (STREAMLINED) Code: 16456 for Schizophrenia. This product is not listed on the PBS for the treatment of Bipolar I disorder
Please review Approved Product Information before prescribing. Product Information is available here or by calling Lundbeck on 1300 721 277
Abilify Asimtufii® is a registered trademark of Otsuka Pharmaceutical Co., Ltd. Level 2/9 Help St, Chatswood NSW 2067, Abilify Asimtufii® is co-commercialised by Lundbeck Australia Pty Ltd and Otsuka Australia Pharmaceutical Pty Ltd.
.
